NAMS
NASDAQ · Biotechnology
Newamsterdam Pharma Co Nv
$18.90
+0.01 (+0.05%)
Performance
1D
+0.00%
1W
-3.37%
1M
-11.10%
3M
-32.45%
6M
-52.26%
1Y
-48.59%
YTD
-46.31%
Open$19.10
Previous Close$18.89
Day High$19.39
Day Low$18.50
52W High$42.21
52W Low$18.86
Volume—
Avg Volume1.70M
Market Cap2.26B
P/E Ratio—
EPS$-2.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.10
Below
SMA 200
$29.47
Below
RSI (14)
41.9
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+92.5% upside
Current
$18.90
$18.90
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.71M | 37.03M | 2.72B |
| Net Income | -205,735,412 | -301,861,543 | 249.35M |
| Profit Margin | -905.7% | -860.5% | 9.2% |
| EBITDA | -227,586,806 | -352,473,859 | 355.91M |
| Free Cash Flow | — | — | 147.67M |
| Rev Growth | -38.7% | -38.7% | +24.9% |
| Debt/Equity | — | — | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |